Literature DB >> 23225361

Migration of resident cardiac stem cells in myocardial infarction.

Simon X Liang1, William D Phillips.   

Abstract

Ischemic heart disease is a major cause of morbidity and mortality worldwide. Stem cell-based therapy, which aims to restore cardiac structure and function by regeneration of functional myocardium, has recently been proposed as a novel alternative treatment modality. Resident cardiac stem cells (CSCs) in adult hearts are a key cell type under investigation. CSCs have been shown to be able to repair damaged myocardium and improve myocardial function in both human and animal studies. This approach relies not only on the proliferation of the CSCs, but also upon their migration to the site of injury within the heart. Here, we briefly review reported CSC populations and discuss signaling factors and pathways required for the migration of CSCs.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23225361     DOI: 10.1002/ar.22633

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  11 in total

1.  In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels.

Authors:  Iman Noshadi; Seonki Hong; Kelly E Sullivan; Ehsan Shirzaei Sani; Roberto Portillo-Lara; Ali Tamayol; Su Ryon Shin; Albert E Gao; Whitney L Stoppel; Lauren D Black; Ali Khademhosseini; Nasim Annabi
Journal:  Biomater Sci       Date:  2017-09-26       Impact factor: 6.843

2.  SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

3.  Intramyocardial Delivery of Notch Ligand-Containing Hydrogels Improves Cardiac Function and Angiogenesis Following Infarction.

Authors:  Archana V Boopathy; Mario D Martinez; Amanda Walker Smith; Milton E Brown; Andrés J García; Michael E Davis
Journal:  Tissue Eng Part A       Date:  2015-07-13       Impact factor: 3.845

4.  Physiological and hypoxic oxygen concentration differentially regulates human c-Kit+ cardiac stem cell proliferation and migration.

Authors:  Michael A Bellio; Claudia O Rodrigues; Ana Marie Landin; Konstantinos E Hatzistergos; Jeffim Kuznetsov; Victoria Florea; Krystalenia Valasaki; Aisha Khan; Joshua M Hare; Ivonne Hernandez Schulman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

Review 5.  The Role of MicroRNAs in Cardiac Stem Cells.

Authors:  Nima Purvis; Andrew Bahn; Rajesh Katare
Journal:  Stem Cells Int       Date:  2015-01-31       Impact factor: 5.443

6.  β-arrestin2 Affects Cardiac Progenitor Cell Survival through Cell Mobility and Tube Formation in Severe Hypoxia.

Authors:  Seul Ki Seo; Nari Kim; Ju Hee Lee; Sang Min Kim; Sang Yeub Lee; Jang Whan Bae; Kyung Kuk Hwang; Dong Woon Kim; Walter J Koch; Myeong Chan Cho
Journal:  Korean Circ J       Date:  2018-04       Impact factor: 3.243

Review 7.  The Role of β-Arrestins in Regulating Stem Cell Phenotypes in Normal and Tumorigenic Cells.

Authors:  Georgios Kallifatidis; Kenza Mamouni; Bal L Lokeshwar
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

8.  Matrix metalloproteinase 9 secreted by hypoxia cardiac fibroblasts triggers cardiac stem cell migration in vitro.

Authors:  Qing Gao; Maojuan Guo; Wenyun Zeng; Yijing Wang; Lin Yang; Xiaoli Pang; Huhu Li; Yanrong Suo; Xijuan Jiang; Chunquan Yu
Journal:  Stem Cells Int       Date:  2015-02-12       Impact factor: 5.443

Review 9.  Cardiac Progenitor Cells and the Interplay with Their Microenvironment.

Authors:  Arianna Mauretti; Sergio Spaans; Noortje A M Bax; Cecilia Sahlgren; Carlijn V C Bouten
Journal:  Stem Cells Int       Date:  2017-09-17       Impact factor: 5.443

Review 10.  Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials.

Authors:  Sara Barreto; Leonie Hamel; Teresa Schiatti; Ying Yang; Vinoj George
Journal:  Cells       Date:  2019-11-28       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.